Sequantrix AI-driven DiseaseDecoder target identification

Research partnerships Announcement Vendor source

Disclosed: Oct 2025 Verified: September 28, 2026 Partners: Sequantrix

Sequantrix announced an agreement with argenx for the use of its AI-driven DiseaseDecoder technology, a computational framework for identifying and evaluating targets.

Source

Vendor Archive pending